Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16Feb 19, 2025
Clinical CRO
Regulatory Approval Clears Path for Oncolytics Biotech to Pancreatic Cancer Treatment
Oncolytics Biotech
PR-01-25-NI-18Jan 16, 2025
Migraine
Biohaven Announces NURTEC® ODT Receives First Global Approval Outside the U.S. For Prevention of Migraine
Biohaven
PR-M12-21-01Dec 13, 2021
Drug Approval
Farxiga Approved in the US for the Treatment of Heart Failure in Patients
AstraZeneca
PR-M05-20-NI-015May 08, 2020
Drug Development
LYNPARZA® (olaparib) Approved by FDA as First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer
Merck & Co.
PR-M01-20-NI-003Jan 02, 2020
Drug Approval
Calquence Approved in the US for Adult Patients with Chronic Lymphocytic Leukemia
AstraZeneca
PR-M11-19-NI-037Nov 25, 2019
Drug Approval
Qtrilmet Approved in the EU for the Treatment of Type-2 Diabetes
Nice Insight
PR-M11-19-NI-020Nov 19, 2019
Vaccine Approval
Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union
Merck & Co.
PR-M11-19-NI-011Nov 13, 2019
Approval
Novartis Gets European Approval to Update Cosentyx Label to Include Dosing Flexibility in Ankylosing Spondylitis
Novartis
PR-M10-19-NI-036Oct 25, 2019
Approval
Farxiga Approved in the US to Reduce the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes
AstraZeneca
PR-M10-19-NI-029Oct 22, 2019
FDA Approval
Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Janssen Pharmaceutical Companies
PR-M10-19-NI-032-2050Oct 22, 2019
Approval
Glenmark Receives Approval for Combination of Remogliflozin Etabonate and Metformin Hydrochloride for Adults With Type 2 Diabetes in India
Glenmark Pharmaceuticals
PR-M08-19-NI-067Aug 23, 2019
Launch
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
Alcon
PR-M08-19-NI-053Aug 20, 2019
FDA Fast Track
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Eli Lilly and Company
PR-M06-19-NI-058Jun 28, 2019
Drug Approval
Emflaza Now Approved for Treatment of Young Children
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M06-19-NI-011Jun 20, 2019
FDA Approval
FDA Approves First Anticoagulant Blood Thinner for Use in Children
Pharma's Almanac
PAO-M05-19-NI-028May 29, 2019
Approval
Triple Combination Treatments for Multiple Myeloma Approved in Europe
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-027May 29, 2019
Prequalification Approval
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
Abbott
PR-M05-19-NI-017May 06, 2019
Approval
Roche Gets New EU Approval for MabThera
Pharma's Almanac
PAO-M03-19-NI-027Mar 20, 2019
Approval
European Commission Approved Tecentriq/Avastin Combination Therapy for Lung Cancer
Pharma's Almanac
PAO-M03-19-NI-018-2902Mar 12, 2019